Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M345Revenue $M44.4Net Margin (%)9.9Z-Score2.9
Enterprise Value $M225EPS $0.1Operating Margin %7.6F-Score8
P/E(ttm))349Cash Flow Per Share $0.4Pre-tax Margin (%)7.7Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %0Quick Ratio18.2Cash flow > EarningsY
Price/Sales8.15-y EBITDA Growth Rate %0Current Ratio18.2Lower Leverage y-yY
Price/Cash Flow6.4y-y EBITDA Growth Rate %0ROA % (ttm)3.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.6ROI % (ttm)-48.7Gross Margin Increase y-yY

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PGNXJulian Robertson 2014-09-30 Buy 1.8%$4.15 - $5.56
($4.99)
$ 5.245%New holding1,290,055
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PGNX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-13Sell3,000$7-13.86view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-11Sell2,000$6.83-11.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-03Sell5,000$6.49-7.09view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.06-14.59view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.07-14.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$7-13.86view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.83-11.71view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-11Sell5,000$6.53-7.66view
Broadfin Healthcare Master Fun10% Owner 2014-07-21Buy1,625,436$4.631.09view
ISRAEL ROBERT JSenior VP Medical Affairs 2013-07-18Sell5,000$6.33-4.74view

Press Releases about PGNX :

    Quarterly/Annual Reports about PGNX:

    News about PGNX:

    Articles On GuruFocus.com
    Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
    Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 26 2013 
    Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
    Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
    5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
    Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
    Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
    Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 

    More From Other Websites
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 24 2015
    RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation... Apr 24 2015
    RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation... Apr 24 2015
    RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation... Apr 24 2015
    RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation... Apr 24 2015
    Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside Apr 16 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 08 2015
    Progenics Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference Apr 08 2015
    Progenics Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference Apr 08 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 07 2015
    Progenics Announces the Initiation of Fuji's Phase 2 Trial for 1404 in Japan Apr 07 2015
    Progenics Announces the Initiation of Fuji's Phase 2 Trial for 1404 in Japan Apr 07 2015
    Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains Mar 25 2015
    PROGENICS PHARMACEUTICALS INC Financials Mar 21 2015
    AstraZeneca, Daiichi Sankyo to Co-Market Movantik in U.S. - Analyst Blog Mar 20 2015
    Actavis' Depression Drug Gains FDA Approval for New Dose - Analyst Blog Mar 17 2015
    PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition Mar 16 2015
    Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial Results Mar 16 2015
    Progenics reports 4Q loss Mar 16 2015
    Progenics reports 4Q loss Mar 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK